Biotech Values

[DewDiligence]

I wonder if this botulinum-toxin patent will stand up to scrutiny:

http://finance.yahoo.com/news/Microdroplet-BOTOX-Technology-bw-981641444.html?x=0&.v=1

Microdroplet™ botulinum toxin (BOTOX®, Dysport®, Xeomin®) is a precise method of elevating the eyebrow position and softening overactive muscles to enhance one’s facial appearance. Whereas standard botulinum toxin treatments involve injecting larger amounts of botulinum toxin in relatively few places, Microdroplet™ botulinum toxin relies on tiny injection volumes of botulinum toxin dissolved in microdroplets. This controlled placement avoids the most common BOTOX® side effects of the “frozen forehead” or “bat face.”